Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Valvular Heart Disease
Interventions
DRUG

(Glucose-Insulin-Potassium)GIK group

infusion of 0.1 IU/kg/hr of insulin and mixture of 30% dextrose water with 80 mmol/l of potassium in the rate of 0.5 ml/kg/hr through out the surgery

DRUG

normal saline group

same rate of normal saline

Trial Locations (1)

120-752

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01825720 - Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery | Biotech Hunter | Biotech Hunter